Literature DB >> 17324514

ABCA1 polymorphisms and Alzheimer's disease.

Fabienne Wavrant-De Vrièze1, Danielle Compton, Meridith Womick, Sampath Arepalli, Omanma Adighibe, Ling Li, Jordi Pérez-Tur, John Hardy.   

Abstract

In our search for genetic factors related to the development of Alzheimer's disease, we have genotyped 332 pedigrees for three coding polymorphisms in the ABCA1 gene, two of which are known to alter plasma cholesterol levels, as well as a non-coding polymorphism within the promoter. We show an apparent weak association of rs2230806 (p-value=0.01) with the disease in a sibpair series of Alzheimer's disease that had shown previously evidence for linkage to the chromosome 9 locus where ABCA1 maps.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324514      PMCID: PMC1945126          DOI: 10.1016/j.neulet.2007.02.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

1.  Results of a high-resolution genome screen of 437 Alzheimer's disease families.

Authors:  Deborah Blacker; Lars Bertram; Aleister J Saunders; Thomas J Moscarillo; Marilyn S Albert; Howard Wiener; Rodney T Perry; Julianne S Collins; Lindy E Harrell; Rodney C P Go; Amy Mahoney; Terri Beaty; M Danielle Fallin; Dimitrios Avramopoulos; Gary A Chase; Marshal F Folstein; Melvin G McInnis; Susan S Bassett; Kimberly J Doheny; Elizabeth W Pugh; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

Review 2.  Molecular genetics of late-onset Alzheimer's disease.

Authors:  M Ilyas Kamboh
Journal:  Ann Hum Genet       Date:  2004-07       Impact factor: 1.670

3.  Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.

Authors:  Radosveta Koldamova; Matthias Staufenbiel; Iliya Lefterov
Journal:  J Biol Chem       Date:  2005-10-05       Impact factor: 5.157

4.  Identification of novel genes in late-onset Alzheimer's disease.

Authors:  M A Pericak-Vance; J Grubber; L R Bailey; D Hedges; S West; L Santoro; B Kemmerer; J L Hall; A M Saunders; A D Roses; G W Small; W K Scott; P M Conneally; J M Vance; J L Haines
Journal:  Exp Gerontol       Date:  2000-12       Impact factor: 4.032

5.  Full genome screen for Alzheimer disease: stage II analysis.

Authors:  Amanda Myers; Fabienne Wavrant De-Vrieze; Peter Holmans; Marian Hamshere; Richard Crook; Danielle Compton; Helen Marshall; David Meyer; Shantia Shears; Jeremy Booth; Dzanan Ramic; Heather Knowles; John C Morris; Nigel Williams; Nadine Norton; Richard Abraham; Pat Kehoe; Hywel Williams; Varuni Rudrasingham; Francis Rice; Peter Giles; Nigel Tunstall; Lesley Jones; Simon Lovestone; Julie Williams; Michael J Owen; John Hardy; Alison Goate
Journal:  Am J Med Genet       Date:  2002-03-08

6.  Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.

Authors:  S Lutucuta; C M Ballantyne; H Elghannam; A M Gotto; A J Marian
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

7.  ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

Authors:  M Axel Wollmer; Johannes R Streffer; Dieter Lütjohann; Magdalini Tsolaki; Vassiliki Iakovidou; Thomas Hegi; Thomas Pasch; Hans H Jung; Klaus von Bergmann; Roger M Nitsch; Christoph Hock; Andreas Papassotiropoulos
Journal:  Neurobiol Aging       Date:  2003 May-Jun       Impact factor: 4.673

Review 8.  Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease.

Authors:  Mark Burns; Karen Duff
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

Review 9.  ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease.

Authors:  Seung Ho Hong; Jeffrey Rhyne; Karen Zeller; Michael Miller
Journal:  Atherosclerosis       Date:  2002-10       Impact factor: 5.162

10.  Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.

Authors:  Hagit Katzov; Katy Chalmers; Juni Palmgren; Niels Andreasen; Boo Johansson; Nigel J Cairns; Margaret Gatz; Gordon K Wilcock; Seth Love; Nancy L Pedersen; Anthony J Brookes; Kaj Blennow; Patrick G Kehoe; Jonathan A Prince
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

View more
  11 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.

Authors:  Radosveta Koldamova; Nicholas F Fitz; Iliya Lefterov
Journal:  Biochim Biophys Acta       Date:  2010-02-24

Review 3.  ATP-binding cassette transporter A1: from metabolism to neurodegeneration.

Authors:  Radosveta Koldamova; Nicholas F Fitz; Iliya Lefterov
Journal:  Neurobiol Dis       Date:  2014-05-17       Impact factor: 5.996

Review 4.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  The Association between Sporadic Alzheimer's Disease and the Human ABCA1 and APOE Gene Polymorphisms in Iranian Population.

Authors:  H R Khorram Khorshid; E Gozalpour; K Kamali; M Ohadi; M Karimloo; M H Shahhosseiny
Journal:  Iran Red Crescent Med J       Date:  2011-04-01       Impact factor: 0.611

6.  A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration.

Authors:  Armin P Piehler; Mustafa Ozcürümez; Wolfgang E Kaminski
Journal:  Front Psychiatry       Date:  2012-03-05       Impact factor: 4.157

7.  ABC Transporters and the Alzheimer's Disease Enigma.

Authors:  Andrea Wolf; Björn Bauer; Anika M S Hartz
Journal:  Front Psychiatry       Date:  2012-06-04       Impact factor: 4.157

8.  Integrated Systems Approach Reveals Sphingolipid Metabolism Pathway Dysregulation in Association with Late-Onset Alzheimer's Disease.

Authors:  John Stephen Malamon; Andres Kriete
Journal:  Biology (Basel)       Date:  2018-02-09

9.  Alterations in Alzheimer's Disease-Associated Gene Expression in Severe Obstructive Sleep Apnea Patients.

Authors:  Hsueh-Yu Li; Ming-Shao Tsai; Chung-Guei Huang; Robert Y L Wang; Li-Pang Chuang; Ning-Hung Chen; Chi-Hung Liu; Cheng-Ming Hsu; Wen-Nuan Cheng; Li-Ang Lee
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

10.  A Comprehensive In Silico Analysis of the Functional and Structural Impact of Nonsynonymous SNPs in the ABCA1 Transporter Gene.

Authors:  Francisco R Marín-Martín; Cristina Soler-Rivas; Roberto Martín-Hernández; Arantxa Rodriguez-Casado
Journal:  Cholesterol       Date:  2014-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.